Okay kiddies for those of you with a business acumen and an eye for detail I will cut you in on the obvious. let's look at this for a moment..
“Tim Heady's appointment as well as the recent addition of Stephen Jaeger to the DARA board reflects the ongoing evolution of both the company and its board of directors.” Drutz quoted as saying
"Tim is another significant addition to the DARA board. His experience in pharmacy and specialty drug management, pharmacy benefits design, and with third-party payers will be of primary relevance to DARA as we continue to grow our oncology-focused specialty pharmaceutical business." Okay so if you're Dave you come in, shake it up a bit and put your chess pieces in place. Surround yourslef with competent proven and successful people and promote a new and aggressive business model. This is planting the seeds for success, now the tree is growing and the low hanging fruit shall soon bare. Planning and strategical approach to business is how many successful businesses are built. Further " Mr. Heady retired in 2011 as CEO of UnitedHealthcare Pharmacy, a unit of UnitedHealthcare (NYSE: UNH) representing more than $11 Billion in annual prescription drug spending. In that role, he was responsible for all aspects of the business, including pharmaceutical rebate contracting, retail pharmacy network development. Put the right people on place and the results are likely to materialize. I posted this as I want everyone to understand that when the news hits it's the culmination of all of the hard work that these people put forth everyday to ensure quality products and success at the business model. Success is gained through hardwork, strategical decisions and planning. That is why I have 180k shares and sleep well at night.....don't sweat the daily moves, think longer term.
The thing that gets me is the leverage any sales will have on this stock with its low float and low expenses. With the micro market cap we have the potential for an incredible move in the stock that turns this into a ten nagger virtually overnight. And none of that includes the bonus of our phase 2 drug. Orphan status and partnership on top of sales would makes us all rich.